Odronextamab
R5837-ONC-2019
Phase 1 small_molecule active
Quick answer
Odronextamab for B-cell Non-Hodgkins Lymphoma (B-NHL) is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- B-cell Non-Hodgkins Lymphoma (B-NHL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active